WebNivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin … WebFor adults with newly diagnosed advanced non-small cell lung cancer. OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small …
Opdivo: Uses, Dosage, Side Effects & Warnings - Drugs.com
WebFeb 28, 2024 · loss of appetite, right upper abdominal pain, unusual weakness, yellowing of the eyes or skin ( jaundice ), swelling of your ankles, feet, and hands, and. weight gain or … Along with its needed effects, nivolumab (the active ingredient contained in Opdivo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediatelyif any of the following side effects occur while taking … See more Some side effects of nivolumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Some side effects may not be … See more imaioptics
Nivolumab (Opdivo®) Macmillan Cancer Support
WebFeb 15, 2024 · Adult patients and pediatric patients age 12 years and older and weighing 40 kg or more: 240 mg every 2 weeks*. or. 480 mg every 4 weeks*. Until disease progression or unacceptable toxicity. Pediatric patients age 12 years and older and weighing less than 40 kg: 3 mg/kg every 2 weeks*. . WebMar 18, 2024 · The most common side effect of chemotherapy is fatigue. Many immunotherapy side effects come from overactivation of your immune system. Mild side effects can include nausea, flu-like symptoms, or ... WebThe most common side effects of OPDIVO, when used in combination with cabozantinib, include: diarrhea; feeling tired or weak; liver problems; rash, redness, pain, swelling or … ima in texting